$Shuttle Pharmaceuticals (SHPH.US)$ Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program Thursday, 19th December at 9:00 am GAITHERSBURG, Md., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma"), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), toda...
$Shuttle Pharmaceuticals (SHPH.US)$ Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules Shuttle Pharmaceuticals Holdings(Nasdaq: SHPH) has announced pricing of a $4.5 million public offering priced at-the-market. The offering includes up to 2,950,820 shares of common stock (or pre-funded warrants) and warrants at $1.525 per share and accompanying warrant. The warrants, exercisable at $1.40 per share, will expire in f...
Stock_Drift OP 152267506 : Calm down. You don’t have to post that every time. In fact I’d highly advise against it. Thanks
Dawit Afeworki : thank you for posting
Stock_Drift OP Dawit Afeworki : You’re welcome
103698897 Coco 小白 : Tks u for posting as reminder
Stock_Drift OP 103698897 Coco 小白 : YW.
View more comments...